ArticleCancers2026

Comprehensive Analysis and Prediction of HER2-Targeted Therapy Insensitivity Among HER2-Positive Breast Cancer Patients Undergoing Neoadjuvant Treatment.

Qingyao Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.